Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.
about
Translating neoadjuvant therapy into survival benefits: one size does not fit all.An objective nodal staging system for breast cancer patients undergoing neoadjuvant systemic treatment.RAS pathway biomarkers for breast cancer prognosis.AEG-1 as a predictor of sensitivity to neoadjuvant chemotherapy in advanced epithelial ovarian cancerDeficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancer.Sentinel lymph nodes for breast carcinoma: an update on current practice.SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast CancerFeasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients.Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size.Trends and controversies in multidisciplinary care of the patient with breast cancer.The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study.Neoadjuvant chemotherapy with MRI monitoring for breast cancer.How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011.Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.Is there an Ideal Breast Conservation Rate for the Treatment of Breast Cancer?Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer.Pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: Perfusion metrics of dynamic contrast enhanced MRI.Neoadjuvant therapy for breast cancer: updates and proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer
P2860
Q30251738-8951B9B5-DA5E-49CD-BE70-A55424D6BADCQ33750517-8759DDF5-02F8-45B0-BB81-B0E78B3EC9C8Q33757299-D7B801D6-48C5-47A6-BE2C-DB68C719C569Q36834096-3694FF47-0855-4B2C-B20E-FCEE9CD66D6CQ36956157-DDD47CBA-1A93-44F2-BF18-3AE633FFDA3BQ37265272-67887D05-A943-4C2A-82FD-529B10D2466FQ37309686-252DABBC-1A84-4C8A-BADE-48305B8855A2Q38399858-31A4BDE9-9D52-4501-88DC-7ED04AE8C131Q38420000-A879F68F-86F9-4FA8-8793-D06A2C285BD9Q39119467-D6695565-2C5A-476B-A3FF-99DE88EC6DBBQ39448618-63334304-0EDE-4BE6-88C4-616C4510D3C9Q40142806-E12D71F6-14A7-427D-9618-9EE82C85E619Q40763024-7924D575-969E-4C87-A127-0A0681E02AC4Q48023842-C1548273-7F6C-4367-9D72-AA92BBBF6C2AQ48308818-F4B77A69-3E51-46B4-9F49-0611AFC8E238Q53101382-548F2D2E-9BD2-4057-856C-8E910615894BQ55000673-B467A9EF-2ECB-437E-AF41-5C4A5CDB058CQ55426221-72A00B30-DAF2-444D-ABB6-8EFCEDACC484Q59135407-72C3597A-7BCD-4F6C-B664-57B758CEB97F
P2860
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.
@en
type
label
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.
@en
prefLabel
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.
@en
P2860
P1476
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.
@en
P2093
Tari A King
P2860
P304
P356
10.1038/NRCLINONC.2015.63
P407
P577
2015-04-07T00:00:00Z